Q3 2025 Management View James Dentzer, President and CEO, emphasized continued progress in the TakeAim Lymphoma study evaluating emavusertib in combination with ibrutinib in primary CNS lymphoma ...
The Investment Adviser Association and the Investment Company Institute voiced support for the two-year postponement, citing a need for tailored anti-money laundering requirements.
On July 21, 2025, the Financial Crimes Enforcement Network (FinCEN) announced its intention to postpone, for two years, the effective date of a final rule subjecting investment advisers to the ...
On Aug. 28, 2024, the Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) issued a final rule (the Final Rule) extending the scope of the Bank Secrecy Act (BSA) and its ...
The Ladbrokes and Neds owner is challenging AUSTRAC allegations, arguing it promptly fixed flaws found by independent ...
Health Enterprises Network (HEN) and Advanced Manufacturing and Logistics Network (AML) celebrated the graduation of 26 ...
(GLOBE NEWSWIRE) -- (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced receipt of a $30 ...
M2T-CD33 (LTI-214) has received FDA orphan drug designation, offering incentives like tax credits and market exclusivity for AML treatment. The treatment targets CD33, a glycoprotein present in 90% of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback